The continuous adverse impact of COVID-19 on temporomandibular disorders and bruxism: comparison of pre- during- and post-pandemic time periods.
Bruxism
COVID-19 pandemic
Gender
Temporomandibular Disorders
Journal
BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684
Informations de publication
Date de publication:
04 10 2023
04 10 2023
Historique:
received:
16
05
2023
accepted:
23
09
2023
medline:
6
10
2023
pubmed:
5
10
2023
entrez:
4
10
2023
Statut:
epublish
Résumé
Some of the conditions affected by the COVID-19 pandemic were Temporomandibular Disorders (TMD) and bruxism. The present study compares the effect of the pandemic on TMD and bruxism (sleep and awake) in three time periods: before the pandemic (pre-COV), during the pandemic (during-COV) and after the pandemic subsided (post-COVR). A total of 587 adult patients (108 in the pre-COV group, 180 in the during-COV group and 252 in the post-COVR group) who arrived for a routine dental treatment between October 2018 and January 2023 were evaluated according to Axis I diagnosis of the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD). Each patient received a DC/TMD Axis I diagnosis as follows: (i) Painful TMD (defined by the presence of at least one of the following - local myalgia, myofascial pain with referral, arthralgia or headache attributed to TMD); (ii) Non painful TMD (defined by the presence of disc displacement with/without reduction, degenerative joint disorders and/or dislocation), (iii) Possible sleep bruxism (SB) and/or (iv) Possible awake bruxism (AB). Logistic regression analyses were conducted to establish the impact of time and gender on the prospects of painful TMD, non-painful TMD, SB and AB. The odds of subjects to be diagnosed with painful TMD at the post-COVR era were 3.3 times higher compared to the pre-pandemic time period (pre-COV, 95% C.I. 1.438-7.585). The odds of subjects to be diagnosed with non-painful TMD during-COV were 4 times higher compared to the pre-COV era (95% C.I. 1.332-12.542). The odds of subjects to present possible SB at post-COVR were 2.7 times higher compared to pre-pandemic (pre-COV, 95% C.I. 1.258-5.889, p < 0.05) and the odds to present possible AB after the pandemic subsided (post-COVR) were 3.2 times compared to the pre-pandemic period (95% C.I. 1.496-6.949). The odds of female subjects to be diagnosed with either painful or non-painful TMD were 3.7-4.4 times higher, compared to males. Results indicate that with regard to TMD and bruxism the pandemic adverse effects persist also after COVID-19 subsides and the restrictions caused by it are abolished. Apparently, during the pandemic females were affected more seriously by painful and non-painful TMD than males.
Identifiants
pubmed: 37794398
doi: 10.1186/s12903-023-03447-4
pii: 10.1186/s12903-023-03447-4
pmc: PMC10552226
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
716Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
J Appl Oral Sci. 2020;28:e20200263
pubmed: 32401942
J Oral Rehabil. 2019 Sep;46(9):845-861
pubmed: 31090938
Head Face Med. 2008 Feb 28;4:4
pubmed: 18307774
J Oral Facial Pain Headache. 2018 Spring;32(2):137-150
pubmed: 29694464
Brain Sci. 2023 Mar 12;13(3):
pubmed: 36979291
J Clin Med. 2021 Apr 08;10(8):
pubmed: 33918017
Crit Rev Oral Biol Med. 1997;8(3):291-305
pubmed: 9260045
Cranio. 2021 Oct 15;:1-6
pubmed: 34652252
Oral Dis. 2016 Oct;22(7):609-19
pubmed: 26704694
Pain. 2011 Mar;152(3 Suppl):S2-S15
pubmed: 20961685
Biol Sex Differ. 2020 Oct 13;11(1):56
pubmed: 33050941
J Dent Res. 2016 Sep;95(10):1084-92
pubmed: 27339423
J Clin Med. 2023 Apr 02;12(7):
pubmed: 37048735
J Clin Med. 2020 Oct 12;9(10):
pubmed: 33053640
J Affect Disord. 2020 Dec 1;277:55-64
pubmed: 32799105
J Pain. 2011 Nov;12(11 Suppl):T4-11.e1-2
pubmed: 22074751
J Neurosci Rural Pract. 2020 Oct;11(4):519-525
pubmed: 33144785
Global Health. 2020 Jul 6;16(1):57
pubmed: 32631403
J Oral Rehabil. 2023 Jan 3;:
pubmed: 36597658
JDR Clin Trans Res. 2023 Apr 21;:23800844231165016
pubmed: 37082861
J Oral Rehabil. 2018 Nov;45(11):837-844
pubmed: 29926505
J Oral Rehabil. 2023 Aug;50(8):706-714
pubmed: 37078711
Clin Oral Investig. 2021 Feb;25(2):441-453
pubmed: 33409693
Int J Mol Sci. 2022 Oct 12;23(20):
pubmed: 36293017
J Oral Rehabil. 2010 Mar;37(3):157-62
pubmed: 20002533
J Dent. 2021 Aug;111:103711
pubmed: 34090993
J Oral Rehabil. 2018 Nov;45(11):881-889
pubmed: 29972707
Pain Res Manag. 2018 May 2;2018:7020751
pubmed: 29854038
Psychol Med. 2021 Apr;51(6):881-893
pubmed: 33648613
J Dent Hyg. 2013 Apr;87(2):73-81
pubmed: 23986140
Cephalalgia. 2017 Jun;37(7):692-704
pubmed: 28068790
J Oral Facial Pain Headache. 2020 Fall;34(4):379-397
pubmed: 33290444
J Affect Disord. 2022 Aug 1;310:384-395
pubmed: 35561885
J Oral Facial Pain Headache. 2016 Summer;30(3):249-54
pubmed: 27472528
BMC Oral Health. 2023 Apr 28;23(1):248
pubmed: 37118748
J Oral Rehabil. 2010 Aug;37(8):624-40
pubmed: 20236235
Lancet. 2021 Nov 6;398(10312):1700-1712
pubmed: 34634250
Lasers Med Sci. 2020 Feb;35(1):181-192
pubmed: 31396794
J Clin Med. 2019 Aug 29;8(9):
pubmed: 31470624
J Oral Rehabil. 2023 Sep;50(9):822-829
pubmed: 37073471
J Clin Med. 2022 Jan 25;11(3):
pubmed: 35160041
Front Neurol. 2020 Dec 09;11:564431
pubmed: 33362686
J Dent Res. 2002 Apr;81(4):284-8
pubmed: 12097315
Int J Environ Res Public Health. 2023 Jan 30;20(3):
pubmed: 36767818
Ind Psychiatry J. 2011 Jan;20(1):4-10
pubmed: 22969173
Sleep Med Rev. 2022 Apr;62:101591
pubmed: 35131664
Clin J Pain. 2013 Aug;29(8):712-6
pubmed: 23343773
J Pers Med. 2022 Aug 07;12(8):
pubmed: 36013244